LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells.

    Pourzia, Alexandra L / Olson, Michael L / Bailey, Stefanie R / Boroughs, Angela C / Aryal, Aditi / Ryan, Jeremy / Maus, Marcela V / Letai, Anthony

    Cell death & disease

    2023  Volume 14, Issue 4, Page(s) 267

    Abstract: Chimeric antigen receptor (CAR) T cell therapy is an FDA-approved treatment for several hematologic malignancies, yet not all patients respond to this treatment. While some resistance mechanisms have been identified, cell death pathways in target cancer ... ...

    Abstract Chimeric antigen receptor (CAR) T cell therapy is an FDA-approved treatment for several hematologic malignancies, yet not all patients respond to this treatment. While some resistance mechanisms have been identified, cell death pathways in target cancer cells remain underexplored. Impairing mitochondrial apoptosis via knockout of Bak and Bax, forced Bcl-2 and Bcl-XL expression, or caspase inhibition protected several tumor models from CAR T killing. However, impairing mitochondrial apoptosis in two liquid tumor cell lines did not protect target cells from CAR T killing. We found that whether a cell was Type I or Type II in response to death ligands explained the divergence of these results, so that mitochondrial apoptosis was dispensable for CART killing of cells that were Type I but not Type II. This suggests that the apoptotic signaling induced by CAR T cells bears important similarities to that induced by drugs. Combinations of drug and CAR T therapies will therefore require tailoring to the specific cell death pathways activated by CAR T cells in different types of cancer cells.
    MeSH term(s) Humans ; Receptors, Chimeric Antigen ; Apoptosis ; Caspases/metabolism ; Cell Line, Tumor ; bcl-2 Homologous Antagonist-Killer Protein/genetics ; bcl-2 Homologous Antagonist-Killer Protein/metabolism ; Neoplasms/therapy
    Chemical Substances Receptors, Chimeric Antigen ; Caspases (EC 3.4.22.-) ; bcl-2 Homologous Antagonist-Killer Protein
    Language English
    Publishing date 2023-04-13
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2541626-1
    ISSN 2041-4889 ; 2041-4889
    ISSN (online) 2041-4889
    ISSN 2041-4889
    DOI 10.1038/s41419-023-05727-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion.

    Olson, Michael L / Mause, Erica R Vander / Radhakrishnan, Sabarinath V / Brody, Joshua D / Rapoport, Aaron P / Welm, Alana L / Atanackovic, Djordje / Luetkens, Tim

    Leukemia

    2022  Volume 36, Issue 7, Page(s) 1943–1946

    MeSH term(s) Humans ; Immunotherapy, Adoptive ; Receptors, Antigen, T-Cell/genetics ; Receptors, Chimeric Antigen/genetics ; T-Lymphocytes ; Trogocytosis
    Chemical Substances Receptors, Antigen, T-Cell ; Receptors, Chimeric Antigen
    Language English
    Publishing date 2022-04-30
    Publishing country England
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-022-01585-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Restricting CAR T Cell Trafficking Expands Targetable Antigen Space.

    Morales, Erin A / Dietze, Kenneth A / Baker, Jillian M / Wang, Alexander / Avila, Stephanie V / Iglesias, Fiorella / Radhakrishnan, Sabarinath V / Mause, Erica Vander / Olson, Michael L / Sun, Wenxiang / Rosati, Ethan / Chidester, Sadie L / Iraguha, Thierry / Fan, Xiaoxuan / Atanackovic, Djordje / Luetkens, Tim

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Chimeric antigen receptor (CAR) T cells are an effective treatment for some blood cancers. However, the lack of tumor-specific surface antigens limits their wider use. We identified a set of surface antigens that are limited in their expression to cancer ...

    Abstract Chimeric antigen receptor (CAR) T cells are an effective treatment for some blood cancers. However, the lack of tumor-specific surface antigens limits their wider use. We identified a set of surface antigens that are limited in their expression to cancer and the central nervous system (CNS). We developed CAR T cells against one of these antigens, LINGO1, which is widely expressed in Ewing sarcoma (ES). To prevent CNS targeting, we engineered LINGO1 CAR T cells lacking integrin α
    Language English
    Publishing date 2024-02-11
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.02.08.579002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity.

    Vander Mause, Erica R / Baker, Jillian M / Dietze, Kenneth A / Radhakrishnan, Sabarinath V / Iraguha, Thierry / Omili, Destiny / Davis, Patricia / Chidester, Sadie L / Modzelewska, Katarzyna / Panse, Jens / Marvin, James E / Olson, Michael L / Steinbach, Mary / Ng, David P / Lim, Carol S / Atanackovic, Djordje / Luetkens, Tim

    Science translational medicine

    2023  Volume 15, Issue 705, Page(s) eadd7900

    Abstract: T cells expressing chimeric antigen receptors (CARs) have shown remarkable therapeutic activity against different types of cancer. However, the wider use of CAR T cells has been hindered by the potential for life-threatening toxicities due to on-target ... ...

    Abstract T cells expressing chimeric antigen receptors (CARs) have shown remarkable therapeutic activity against different types of cancer. However, the wider use of CAR T cells has been hindered by the potential for life-threatening toxicities due to on-target off-tumor killing of cells expressing low amounts of the target antigen. CD229, a signaling lymphocyte-activation molecule (SLAM) family member, has previously been identified as a target for CAR T cell-mediated treatment of multiple myeloma (MM) due to its high expression on the surfaces of MM cells. CD229 CAR T cells have shown effective clearance of MM cells in vitro and in vivo. However, healthy lymphocytes also express CD229, albeit at lower amounts than MM cells, causing their unintended targeting by CD229 CAR T cells. To increase the selectivity of CD229 CAR T cells for MM cells, we used a single amino acid substitution approach of the CAR binding domain to reduce CAR affinity. To identify CARs with increased selectivity, we screened variant binding domains using solid-phase binding assays and biolayer interferometry and determined the cytotoxic activity of variant CAR T cells against MM cells and healthy lymphocytes. We identified a CD229 CAR binding domain with micromolar affinity that, when combined with overexpression of c-Jun, confers antitumor activity comparable to parental CD229 CAR T cells but lacks the parental cells' cytotoxic activity toward healthy lymphocytes in vitro and in vivo. The results represent a promising strategy to improve the efficacy and safety of CAR T cell therapy that requires clinical validation.
    MeSH term(s) Humans ; Multiple Myeloma/pathology ; Amino Acids/metabolism ; T-Lymphocytes ; Receptors, Chimeric Antigen/metabolism ; Immunotherapy, Adoptive/methods ; Antineoplastic Agents/metabolism ; Xenograft Model Antitumor Assays ; Cell Line, Tumor
    Chemical Substances Amino Acids ; Receptors, Chimeric Antigen ; Antineoplastic Agents
    Language English
    Publishing date 2023-07-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2518854-9
    ISSN 1946-6242 ; 1946-6234
    ISSN (online) 1946-6242
    ISSN 1946-6234
    DOI 10.1126/scitranslmed.add7900
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide.

    Radhakrishnan, Sabarinath V / Luetkens, Tim / Scherer, Sandra D / Davis, Patricia / Vander Mause, Erica R / Olson, Michael L / Yousef, Sara / Panse, Jens / Abdiche, Yasmina / Li, K David / Miles, Rodney R / Matsui, William / Welm, Alana L / Atanackovic, Djordje

    Nature communications

    2020  Volume 11, Issue 1, Page(s) 798

    Abstract: Multiple myeloma (MM) is a plasma cell malignancy and most patients eventually succumb to the disease. Chimeric antigen receptor (CAR) T cells targeting B-Cell Maturation Antigen (BCMA) on MM cells have shown high-response rates, but limited durability. ... ...

    Abstract Multiple myeloma (MM) is a plasma cell malignancy and most patients eventually succumb to the disease. Chimeric antigen receptor (CAR) T cells targeting B-Cell Maturation Antigen (BCMA) on MM cells have shown high-response rates, but limited durability. CD229/LY9 is a cell surface receptor present on B and T lymphocytes that is universally and strongly expressed on MM plasma cells. Here, we develop CD229 CAR T cells that are highly active in vitro and in vivo against MM plasma cells, memory B cells, and MM-propagating cells. We do not observe fratricide during CD229 CAR T cell production, as CD229 is downregulated in T cells during activation. In addition, while CD229 CAR T cells target normal CD229
    MeSH term(s) Animals ; Antibodies/immunology ; B-Lymphocytes/metabolism ; Humans ; Immunotherapy, Adoptive/methods ; K562 Cells/immunology ; Male ; Mice, Inbred NOD ; Multiple Myeloma/pathology ; Multiple Myeloma/therapy ; Receptors, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell/metabolism ; Signaling Lymphocytic Activation Molecule Family/genetics ; Signaling Lymphocytic Activation Molecule Family/immunology ; Signaling Lymphocytic Activation Molecule Family/metabolism ; T-Lymphocytes/immunology ; T-Lymphocytes/transplantation ; Xenograft Model Antitumor Assays
    Chemical Substances Antibodies ; LY9 protein, human ; Receptors, Antigen, T-Cell ; Signaling Lymphocytic Activation Molecule Family
    Language English
    Publishing date 2020-02-07
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-020-14619-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites

    Veldkamp, Christopher T / Kiermaier Eva / Gabel-Eissens Skylar J / Gillitzer Miranda L / Lippner David R / DiSilvio Frank A / Mueller Casey J / Wantuch Paeton L / Chaffee Gary R / Famiglietti Michael W / Zgoba Danielle M / Bailey Asha A / Bah Yaya / Engebretson Samantha J / Graupner David R / Lackner Emily R / LaRosa Vincent D / Medeiros Tysha / Olson Michael L /
    Phillips Andrew J / Pyles Harley / Richard Amanda M / Schoeller Scott J / Touzeau Boris / Williams Larry G / Sixt Michael / Peterson Francis C

    Biochemistry. 2015 July 14, v. 54, no. 27

    2015  

    Abstract: CCL19 and CCL21 are chemokines involved in the trafficking of immune cells, particularly within the lymphatic system, through activation of CCR7. Concurrent expression of PSGL-1 and CCR7 in naive T-cells enhances recruitment of these cells to secondary ... ...

    Abstract CCL19 and CCL21 are chemokines involved in the trafficking of immune cells, particularly within the lymphatic system, through activation of CCR7. Concurrent expression of PSGL-1 and CCR7 in naive T-cells enhances recruitment of these cells to secondary lymphoid organs by CCL19 and CCL21. Here the solution structure of CCL19 is reported. It contains a canonical chemokine domain. Chemical shift mapping shows the N-termini of PSGL-1 and CCR7 have overlapping binding sites for CCL19 and binding is competitive. Implications for the mechanism of PSGL-1’s enhancement of resting T-cell recruitment are discussed.
    Keywords CCR7 receptor ; T-lymphocytes ; binding sites ; chemokine CCL19 ; chemokine CCL21 ; lymphatic system
    Language English
    Dates of publication 2015-0714
    Size p. 4163-4166.
    Publishing place American Chemical Society
    Document type Article
    ZDB-ID 1108-3
    ISSN 1520-4995 ; 0006-2960
    ISSN (online) 1520-4995
    ISSN 0006-2960
    DOI 10.1021%2Facs.biochem.5b00560
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites.

    Veldkamp, Christopher T / Kiermaier, Eva / Gabel-Eissens, Skylar J / Gillitzer, Miranda L / Lippner, David R / DiSilvio, Frank A / Mueller, Casey J / Wantuch, Paeton L / Chaffee, Gary R / Famiglietti, Michael W / Zgoba, Danielle M / Bailey, Asha A / Bah, Yaya / Engebretson, Samantha J / Graupner, David R / Lackner, Emily R / LaRosa, Vincent D / Medeiros, Tysha / Olson, Michael L /
    Phillips, Andrew J / Pyles, Harley / Richard, Amanda M / Schoeller, Scott J / Touzeau, Boris / Williams, Larry G / Sixt, Michael / Peterson, Francis C

    Biochemistry

    2015  Volume 54, Issue 27, Page(s) 4163–4166

    Abstract: CCL19 and CCL21 are chemokines involved in the trafficking of immune cells, particularly within the lymphatic system, through activation of CCR7. Concurrent expression of PSGL-1 and CCR7 in naive T-cells enhances recruitment of these cells to secondary ... ...

    Abstract CCL19 and CCL21 are chemokines involved in the trafficking of immune cells, particularly within the lymphatic system, through activation of CCR7. Concurrent expression of PSGL-1 and CCR7 in naive T-cells enhances recruitment of these cells to secondary lymphoid organs by CCL19 and CCL21. Here the solution structure of CCL19 is reported. It contains a canonical chemokine domain. Chemical shift mapping shows the N-termini of PSGL-1 and CCR7 have overlapping binding sites for CCL19 and binding is competitive. Implications for the mechanism of PSGL-1's enhancement of resting T-cell recruitment are discussed.
    MeSH term(s) Binding Sites ; Chemokine CCL19/chemistry ; Chemokine CCL19/metabolism ; Humans ; Membrane Glycoproteins/metabolism ; Models, Molecular ; Protein Conformation ; Receptors, CCR7/metabolism
    Chemical Substances CCR7 protein, human ; Chemokine CCL19 ; Membrane Glycoproteins ; P-selectin ligand protein ; Receptors, CCR7
    Language English
    Publishing date 2015-07-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1108-3
    ISSN 1520-4995 ; 0006-2960
    ISSN (online) 1520-4995
    ISSN 0006-2960
    DOI 10.1021/acs.biochem.5b00560
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites

    Veldkamp, Christopher T. / Kiermaier EvaauthorIST Austria (Institute for Science and Technology Austria), 3400 Klosterneuburg, Austria / Gabel-Eissens Skylar J.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Gillitzer Miranda L.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Lippner David R.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / DiSilvio Frank A.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Mueller Casey J.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Wantuch Paeton L.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Chaffee Gary R.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Famiglietti Michael W.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Zgoba Danielle M.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Bailey Asha A.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Bah YayaauthorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Engebretson Samantha J.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Graupner David R.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Lackner Emily R.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / LaRosa Vincent D.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Medeiros TyshaauthorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Olson Michael L.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States /
    Phillips Andrew J.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Pyles HarleyauthorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Richard Amanda M.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Schoeller Scott J.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Touzeau BorisauthorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Williams Larry G.authorDepartment of Chemistry, University of WisconsinWhitewater, 800 West Main Street, Whitewater, Wisconsin 53190, United States / Sixt MichaelauthorIST Austria (Institute for Science and Technology Austria), 3400 Klosterneuburg, Austria / Peterson Francis C.authorDepartment of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, United States
    Language English
    Document type Article
    Database AGRIS - International Information System for the Agricultural Sciences and Technology

    More links

    Kategorien

To top